Search

Your search keyword '"Villoria, Albert"' showing total 191 results

Search Constraints

Start Over You searched for: Author "Villoria, Albert" Remove constraint Author: "Villoria, Albert"
191 results on '"Villoria, Albert"'

Search Results

1. Inflammatory bowel disease in axial spondyloarthritis patients. Is there any specific clinical picture? Data from the RESPONDIA and REGISPONSER registries.

2. Efficacy of Beclomethasone Dipropionate in Lowering Fecal Calprotectin Levels in Patients with Ulcerative Colitis in Clinical Remission and at Risk of Relapse: The Becalcu Randomized, Controlled Trial.

3. Economic impact of inflammatory bowel disease in Catalonia: a population-based analysis

4. Incidence of Myelotoxicity and Other Adverse Effects Related to Thiopurine Starting in Patients with Inflammatory Bowel Disease: Retrospective Observational Study in a Third-Level Hospital

5. Genetic biomarkers of methotrexate response and safety in Crohn's disease: Data from the Spanish ENEIDA registry.

6. Antitumor Necrosis Factor Agents to Treat Endoscopic Postoperative Recurrence of Crohnʼs Disease: A Nationwide Study With Propensity-Matched Score Analysis

7. 74 - EXPERIENCIA CON LA REINDUCCIÓN E INTENSIFICACIÓN DE USTEKINUMAB Y FACTORES PRONÓSTICOS ASOCIADOS

8. 56 - IMPACTO ECONÓMICO DE LA ENFERMEDAD INFLAMATORIA INTESTINAL EN CATALUÑA

9. ENSAYO CLÍNICO ALEATORIZADO COMPARATIVO DEL EFECTO DE MEGABOLOS DE CORTICOIDES INTRAVENOSOS AÑADIDOS A LOS CORTICOIDES ORALES EN EL TRATAMIENTO DE LA CU CON ACTIVIDAD MODERADA

10. Effectiveness of adalimumab for the treatment of ulcerative colitis in clinical practice: comparison between anti-tumour necrosis factor-naïve and non-naïve patients

13. Erratum to: Effectiveness of adalimumab for the treatment of ulcerative colitis in clinical practice: comparison between anti-tumour necrosis factor-naïve and non-naïve patients

15. Prevalence of Malnutrition and Nutritional Characteristics of Patients With Inflammatory Bowel Disease

22. Effectiveness and safety of ustekinumab in ulcerative colitis: Real-world evidence from the ENEIDA registry

23. UPLC-MS peak table for preliminary analysis of the association between fatigue and the plasma lipidomic profile of inflammatory bowel disease patients

25. Fendrix vs Engerix-B for Primo-Vaccination Against Hepatitis B Infection in Patients With Inflammatory Bowel Disease: A Randomized Clinical Trial

30. Antitumor Necrosis Factor Agents to Treat EndoscopicPostoperative Recurrence of Crohn’s Disease: A Nationwide Study With Propensity-Matched Score Analysis

31. Time Trends of Crohn's Disease in Catalonia from 2011 to 2017. Increasing Use of Biologics Correlates with a Reduced Need for Surgery

32. A Prospective Pilot Randomized Study: Electroacupuncture vs. Sham Procedure for the Treatment of Fatigue in Patients With Quiescent Inflammatory Bowel Disease

36. Ustekinumab for the Treatment of Refractory Crohnʼs Disease

38. Cost-minimization analysis favours intravenous ferric carboxymaltose over ferric sucrose or oral iron as preoperative treatment in patients with colon cancer and iron deficiency anaemia

41. Sa1260 Durability of the anti-HBs Titers After Vaccination Against Hepatitis B Virus (HBV) in Patients With Inflammatory Bowel Disease (IBD)

42. Sa1267 Prospective, Randomized Clincal Trial Comparing the Efficacy of Two Vaccines Against Hepatis B Virus (HBV) in Inflamatory Bowel Disease (IBD) Patients

44. Respuesta

45. Mo1740 Prospective, Randomized Clinical Trial Comparing the Efficacy of Two Vaccines Against Hepatitis B Virus (HBV) in Inflammatory Bowel Disease (IBD) Patients

46. Tu1285 Endocopist's Clinical Judgment vs. Scoring Systems in Predicting Outcome in Bleeding Peptic Ulcer. Results of a Prospective and Multicenter Study

48. Sa1903 Effectiveness and Safety of Ustekinumab as Rescue Therapy in Multi-Drug Resistant Crohn's Disease

Catalog

Books, media, physical & digital resources